Azhar Kalim Quotient Clinical
Nottingham, England-based drug development services provider, Quotient Clinical, has announced Azhar Kalim as CCO.
According to Quotient, Kalim’s role will include directing the global commercial team in terms of strategic marketing, business development, innovation, key account management, and customer service to biotech and pharmaceutical clients.
“Azhar will lead the enhanced commercial team in a new role, with a focus on supporting Quotient’s strategy to further develop its global commercial footprint following two recent US acquisitions,” said the firm.
Kalim’s experience to date includes formulations development, GMP drug product manufacturing and early stage clinical trials.
Quotient recently announced it has acquired early phase clinical pharmacology business SeaView Research and small molecule formulation development and manufacturing-focused QS Pharma.
“I am delighted to be joining a dynamic and rapidly expanding business, and I look forward to working with the team to build long term, sustainable, and strategic relationships with our customers,” Kalim said.
